| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | Australia | 3 | |
| #3 | Canada | 3 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | Republic of Korea | 2 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Xu Jing | 16 |
| #2 | Rui Lingyun | 16 |
| #3 | Li Yue-Sheng | 14 |
| #4 | Li Yue Sheng | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020252418A2 | Novel interleukin-2 variants for the treatment of cancer | |
| WO2020252421A2 | Novel interleukin-2 variants and bifunctional fusion molecules thereof | |
| WO2019246392A1 | Cytokine-based bioactivatable drugs and methods of uses thereof | |
| WO2019246404A1 | Interleukin-2 variants and methods of uses thereof | |
| KR20210033994A | Novel interleukin-15 (IL-15) fusion protein and uses thereof |